Cargando…
The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19
There is a need for treatments to reduce coronavirus disease 2019 (COVID-19) mortality. Alpha-2 adrenergic receptor (α(2) AR) agonists can dampen immune cell and inflammatory responses as well as improve oxygenation through physiologic respiratory parameters. Therefore, α(2) AR agonists may be effec...
Autores principales: | Hamilton, John L., Vashi, Mona, Kishen, Ekta B., Fogg, Louis F., Wimmer, Markus A., Balk, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764306/ https://www.ncbi.nlm.nih.gov/pubmed/35059419 http://dx.doi.org/10.3389/fmed.2021.797647 |
Ejemplares similares
-
The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19
por: Rose, Liam, et al.
Publicado: (2021) -
Inpatient Administration of Alpha-1-Adrenergic Receptor Blocking Agents Reduces Mortality in Male COVID-19 Patients
por: Li, Shilong, et al.
Publicado: (2022) -
An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity
por: Beak, Ju Youn, et al.
Publicado: (2017) -
Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
por: Ballesteros, Jesus Javier, et al.
Publicado: (2020) -
An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice
por: Montgomery, Megan D., et al.
Publicado: (2017)